{"id":39406,"date":"2020-05-06T10:06:28","date_gmt":"2020-05-06T10:06:28","guid":{"rendered":"https:\/\/setterwalls.se\/case\/setterwalls-advises-klaria-pharma-holding-ab-publ-in-connection-with-a-directed-share-issue\/"},"modified":"2022-02-14T13:44:23","modified_gmt":"2022-02-14T13:44:23","slug":"setterwalls-advises-klaria-pharma-holding-ab-publ-in-connection-with-a-directed-share-issue","status":"publish","type":"assignments","link":"https:\/\/setterwalls.se\/en\/case\/setterwalls-advises-klaria-pharma-holding-ab-publ-in-connection-with-a-directed-share-issue\/","title":{"rendered":"Setterwalls advises Klaria Pharma Holding AB (publ) in connection with a directed share issue"},"content":{"rendered":"<p><strong>Setterwalls acts as legal advisor to Klaria Pharma Holding AB (publ) (\u201cKlaria\u201d or the \u201cCompany\u201d), whose shares are listed on Nasdaq First North Growth Market, in connection with a directed issue to Swedish and international institutional investors, on the basis of a market sounding process carried out by the Company\u2019s financial advisors, V\u00e4stra Hamnen Corporate Finance.<\/strong><\/p>\n<p>The directed new issue was resolved by the board of directors based on their authorization from the annual general meeting. In connection with the share issue, a loan was raised from a consortium of Swedish investors. Klaria is a Swedish listed pharmaceutical company that, by combining patented technology of a film that attaches to the oral mucosa and well proven pharmaceuticals, has developed a drug distribution concept with many benefits and potential uses. The directed share issue will, inter alia, enable ambitious investments in more clinical programs.<\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong>Setterwalls acts as legal advisor to Klaria Pharma Holding AB (publ) (\u201cKlaria\u201d or the \u201cCompany\u201d), whose shares are listed on Nasdaq First North Growth Market, in connection with a directed issue to Swedish and international institutional investors, on the basis of a market sounding process carried out by the Company\u2019s financial advisors, V\u00e4stra Hamnen Corporate Finance.<\/strong><\/p>\n<p>The directed new issue was resolved by the board of directors based on their authorization from the annual general meeting. In connection with the share issue, a loan was raised from a consortium of Swedish investors. Klaria is a Swedish listed pharmaceutical company that, by combining patented technology of a film that attaches to the oral mucosa and well proven pharmaceuticals, has developed a drug distribution concept with many benefits and potential uses. The directed share issue will, inter alia, enable ambitious investments in more clinical programs.<\/p>\n","protected":false},"author":1,"featured_media":34184,"template":"","meta":{"_acf_changed":false,"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":""},"class_list":["post-39406","assignments","type-assignments","status-publish","has-post-thumbnail","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/assignments\/39406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/assignments"}],"about":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/types\/assignments"}],"author":[{"embeddable":true,"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/users\/1"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/media\/34184"}],"wp:attachment":[{"href":"https:\/\/setterwalls.se\/en\/wp-json\/wp\/v2\/media?parent=39406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}